A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms

J Clin Lab Anal. 2018 Sep;32(7):e22440. doi: 10.1002/jcla.22440. Epub 2018 Apr 16.

Abstract

Background: Inosine triphosphate pyrophosphatase (ITPA) gene single nucleotide polymorphisms (SNPs), rs1127354 and rs7270101, may cause a functional impairment in ITPase enzyme, resulting anemia protection in patients with chronic hepatitis C virus (HCV) infection undergoing ribavirin (RBV)-dependent regimens. The main purpose of this study was to provide and validate a simple, rapid, and inexpensive polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique for genotyping of ITPA rs1127354 and rs7270101 polymorphisms in chronic HCV-infected patients.

Methods: In the current study, 100 Iranian patients with chronic hepatitis C were examined and genotyped for ITPA rs1127354 and rs7270101 gene polymorphisms. To genotype rs1127354 and rs7270101 polymorphisms, PCR-RFLP technique and sequencing technique were performed on these samples. To validate the PCR-RFLP method, the PCR-RFLP genotyping results should be 100% concordant with the PCR-sequencing results.

Results: The rs1127354 and rs7270101 polymorphisms of ITPA gene were genotyped by PCR-RFLP technique and sequencing simultaneously, and the results of both techniques were 100% concordant in all 100 patients. Both PCR-RFLP and sequencing techniques indicated that the genotypic frequency of rs7270101 was 80% AA, 19% AC and 1% CC, and for rs1127354 was 79% CC, 20% CA and 1% AA, respectively.

Conclusion: We developed and validated a rapid and inexpensive PCR-RFLP technique for the detection of ITPA rs1127354 and rs7270101 gene polymorphisms.

Keywords: hepatitis C virus; inosine triphosphate pyrophosphatase gene; polymerase chain reaction; restriction fragment length polymorphism; sequencing; single nucleotide polymorphisms.

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cohort Studies
  • Female
  • Genotyping Techniques / methods*
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / epidemiology*
  • Hepatitis C, Chronic / genetics*
  • Humans
  • Iran / epidemiology
  • Male
  • Polymerase Chain Reaction / methods
  • Polymorphism, Restriction Fragment Length / genetics*
  • Polymorphism, Single Nucleotide / genetics
  • Pyrophosphatases / genetics*
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Ribavirin
  • Pyrophosphatases
  • ITPA protein, human